Frontlight ResearchEarly access
Childhood cancers trials in United States
933 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Enrolling by invitationLong-Term Follow-Up Study After Gene-Modified Cell Treatment in Kite Studies
- Where
- Austin, Baltimore, Boston, Buffalo, Charlottesville, Chicago, Cleveland, Columbus, Dallas, Denver, Detroit, Duarte, Durham, Gilbert, Greenville, Hackensack, Houston, Iowa City, La Jolla, Los Angeles, Maywood, Miami, Nashville, New York, Omaha, Orange, Palo Alto, Philadelphia, Pittsburgh, Richmond, Rochester, Sacramento, Salt Lake City, San Antonio, San Francisco, Seattle, St Louis, Tampa, The Bronx, Washington D.C., Westwood
- People
- 1,500 worldwide
- Run by
- Kite, A Gilead Company
See details and how to joinNCT05041309 · EU 2023-507041-28-00 - Phase 1Taking peopleEdetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- Where
- Houston
- Age
- 1 year and over
- People
- 58
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03630991 - Phase 1/2Taking peopleA Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib
- Where
- Baltimore, Boston, Houston, New York
- Age
- 12 years and over
- People
- 8
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06284486 - Phase 2Taking peopleA Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy)
- Where
- Houston
- Age
- 1 month to 21 years
- People
- 22
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06561074 - No phaseTaking peopleDoD Award NF230020 Identification of Metabolic Markers and Statistical Prediction of MPNST for Rapid Diagnosis and Assessment of Surgical Margins
- Where
- Houston
- Age
- 1 year and over
- People
- 60
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07298083 - Phase 2Taking peopleA Phase 2 Study of Radiotherapy-induced Immune Priming to Enhance Elranatamab (Elra) in Relapsed Refractory Multiple Myeloma (RRMM) With Extramedullary Disease (EMD) and Paramedullary Disease (PMD) "PRIME-EMD-PMD"
- Where
- Houston
- People
- 34
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07382739 - Phase 3Taking peopleComparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- People
- 224
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07548164 - No phaseTaking peopleBone Marrow Imaging and Clinical Outcomes Across Hematologic, Oncologic, and Other Relevant Conditions
- Where
- Houston
- People
- 1,000
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07743476 - Phase 3Taking peopleA Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
- Where
- Akron, Albany, Albuquerque, Allentown, Ann Arbor, Asheville, Atlanta, Augusta, Aurora, Austin, Baltimore, Bangor, Bethesda, Birmingham, Boise, Boston, Brooklyn, Buffalo, Burlington, Chapel Hill, Charleston, Charlotte, Charlottesville, Chattanooga, Chicago, Cincinnati, Cleveland, Columbia, Columbus, Corpus Christi, Dallas, Danville, Dayton, Denver, Des Moines, Detroit, Downey, Duarte, Durham, East Lansing, El Paso, Falls Church, Fargo, Fort Lauderdale, Fort Myers, Fort Worth, Gainesville, Grand Rapids, Green Bay, Greenville, Hackensack, Hartford, Hershey, Hollywood, Honolulu, Houston, Indianapolis, Iowa City, Jackson, Jacksonville, Kalamazoo, Kansas City, Knoxville, Las Vegas, Lebanon, Lexington, Little Rock, Loma Linda, Long Beach, Los Angeles, Louisville, Loxahatchee Groves, Madera, Madison, Marshfield, Maywood, Mesa, Miami, Milwaukee, Mineola, Minneapolis, Mobile, Morristown, Nashville, Neptune City, Newark, New Brunswick, New Haven, New Hyde Park, New Orleans, New York, Norfolk, Oakland, Oak Lawn, Oklahoma City, Omaha, Orange, Orlando, Palo Alto, Park Ridge, Paterson, Pensacola, Peoria, Philadelphia, Phoenix, Pittsburgh, Portland, Portsmouth, Providence, Reno, Richmond, Roanoke, Rochester, Royal Oak, Sacramento, Salt Lake City, San Antonio, San Diego, San Francisco, Santa Barbara, Savannah, Scarborough, Seattle, Sioux Falls, Spokane, Springfield, St Louis, Stony Brook, St. Petersburg, Syracuse, Tacoma, Tampa, Temple, The Bronx, Toledo, Tucson, Valhalla, Washington D.C., West Palm Beach, Wilmington, Winston-Salem, Worcester
- Age
- 6 months to 21 years
- People
- 1,400 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT04293562 - Phase 2Taking peopleA Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia
- Where
- Boston, Charlotte, Chicago, Cincinnati, Fort Worth, Madera, Memphis, Orange, San Diego, Washington D.C.
- Age
- 29 days to 21 years
- People
- 70
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT05955261 - Phase 1Taking peopleTumor Infiltrating Lymphocyte Therapy for Pediatric High Risk Solid Tumors
- Where
- St. Petersburg
- Age
- 1 year to 21 years
- People
- 30
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
See details and how to joinNCT06047977 - Phase 1Taking peopleClinical Study of Anti-FLT3 CAR-T Cells for the Treatment of Relapsed/Refractory AML
- Where
- Houston
- Age
- 12 years and over
- People
- 18
- Run by
- Hemogenyx Pharmaceuticals LLC
See details and how to joinNCT06786533 - Phase 1Not yet taking people in United StatesEWSR1 Immunotherapy in Ewing Sarcoma and DSRCT
- Where
- Cleveland
- Age
- 2 years and over
- People
- 24
- Run by
- Rabi Hanna
See details and how to joinNCT07695311 - No phaseTaking peopleProof-of-Concept Testing of the Cardiovascular Health Equity Through Food (CHEF) Intervention in Childhood Cancer Survivors
- Where
- Boston
- Age
- Up to 18 years
- People
- 17
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT06609473 - No phaseTaking peopleQuality of Life and Function of Patients With Pelvic Tumors After Undergoing Hemipelvectomy
- Where
- Houston
- People
- 500
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT05134142 - Phase 2Taking peopleMolecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
- Where
- Ann Arbor, Dallas, Fort Worth, Houston, Memphis, Minneapolis, Orlando, Palo Alto, Salt Lake City, Tampa
- Age
- Up to 59 months
- People
- 130
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT05535166 - Phase 1Taking peopleA Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors
- Where
- Orange
- Age
- 5 years to 18 years
- People
- 12
- Run by
- Neonc Technologies, Inc.
See details and how to joinNCT06357377 - Phase 1Taking peopleA Phase I Study of Hyper-CVAD In Combination With Venetoclax In Pediatric Patients With Relapsed or Refractory Acute Leukemias That Are of the Lymphoid Lineage Including Bi-Phenotypic or Undifferentiated Leukemias
- Where
- Houston
- Age
- 2 years to 21 years
- People
- 22
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06466395 - Phase 1Taking peopleA Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia
- Where
- Memphis
- Age
- Up to 25 years
- People
- 29
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT06810583 - Phase 2Taking peopleGadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System
- Where
- Portland
- Age
- 10 years and over
- People
- 150
- Run by
- OHSU Knight Cancer Institute
See details and how to joinNCT03270059 - Phase 1/2Taking peopleUCD19 CarT in Treatment of Pediatric B-ALL and B-NHL
- Where
- Aurora
- Age
- 31 days to 30 years
- People
- 45
- Run by
- University of Colorado, Denver
See details and how to joinNCT04544592 - No phaseTaking peopleThe Rise in Robotic Atypical Segmentectomies
- Where
- Houston
- People
- 600
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04644952 - No phaseTaking peopleEstablishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix
- Where
- Houston
- People
- 750
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04723095 - Phase 2Taking peopleImpact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia
- Where
- Houston
- People
- 312
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04984551 - No phaseTaking peopleBiomarkers of Resiliency In Childhood Cancer Surgery
- Where
- Rochester
- Age
- 3 years to 25 years
- People
- 40
- Run by
- Mayo Clinic
See details and how to joinNCT06674811